BioCentury
ARTICLE | Company News

Carlyle Group to acquire J&J's Ortho-Clinical Diagnostics business

March 31, 2014 11:42 PM UTC

Johnson & Johnson (NYSE:JNJ) accepted a binding offer from asset manager The Carlyle Group to acquire the pharma's Ortho-Clinical Diagnostics business for $4.2 billion in cash. The pharma does not bre...